Patent 9096657 was granted and assigned to Visterra Inc. on August, 2015 by the United States Patent and Trademark Office.
This disclosure relates to novel peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.